Chengdu Olymvax Biopharmaceuticals Inc. Class ASSE: 688319

Report for Q1 2026

Apr 30, 2026 · Issued by Chengdu Olymvax Biopharmaceuticals Inc. Class A via Shanghai Stock Exchange

Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment